Erythema
51
1
3
39
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
21 trials with published results (41%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
5.9%
3 terminated out of 51 trials
92.9%
+6.4% vs benchmark
18%
9 trials in Phase 3/4
54%
21 of 39 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 39 completed trials
Clinical Trials (51)
Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer
Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulgaris
Effect of Cream Paste Containg Pleuran on Selected Skin Dermatoses (Neonatal Pustulosis, Diaper Dermatitis, Perioral Dermatitis).
Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy
The Effect of 16-week Dietary Intake of Food Supplements Containing Collagen and MSM on Facial Erythema and Other Skin Parameters
Skin Protectant Textile Efficacy Study for Managing Skin Fold Conditions
Study to Evaluate the Sensitizing Potential of MOB015B in Healthy Subjects Using a Repeat Insult Patch Test Design
Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test Design
Characterisation of the Time-course Response of UV-induced Erythema
Evaluation of a Novel Amino Acid Based Moisturizing Cream as Part of the Daily Standard Skincare Regimen Recommended During Radiation Therapy
Irritation Potential of Omeza Collagen Matrix Using Modified HRIPT
Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema
Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne
Skin Protectant Properties of Omeza Collagen Matrix on Damaged Skin
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
A Pilot Study of Warm and Cold Compress to Reduce Injection Site Erythema Due to Peginterferon-beta-1a in MS
An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea
Durapore vs. Hy-Tape to Secure The Endotracheal Tube
Patient-Reported Outcome Of Facial Erythema (PROOF)
Effects of Phytonutrients on Vascular Health and Skin in Obese Males